MedPath

The effect of drop pilocarpine on oral lesions in pemphigus vulgaris

Phase 2
Conditions
L10.0
pemphigus vulgaris oral lesions.
Pemphigus vulgaris
Registration Number
IRCT20221002056070N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
42
Inclusion Criteria

Clinical and histopathological confirmation of pemphigus vulgaris
Patients with resistant oral ulcers that have not been treated with systemic drugs or have relapsed after treatment
Age between 20-70
Accessible mouth lesions(retromolar trigone)

Exclusion Criteria

oral lesions more than 2-3

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Size of oral lesions. Timepoint: Baseline visit, week 4 and week 8. Method of measurement: Measuring the size of lesions in photos by software, evaluation of patient satisfaction, oral lesion status and disease severity using VAS, ODSS and PDAI questionnaires.
Secondary Outcome Measures
NameTimeMethod
Pemphigus disease area index (PDAI). Timepoint: Baseline visit and week 8. Method of measurement: Pemphigus disease area index questionnaire (PDAI).
© Copyright 2025. All Rights Reserved by MedPath